What is it about?
We explain how to deduce therapeutic alternatives based on pharmacokinetic and pharmacodynamic principles in the absence of direct clinical evidence.
Featured Image
Why is it important?
The lack of direct clinical evidence does not mean that a recommendation cannot be made when addressing essential drug shortages. The conscientious, explicit, and judicious use of the next best external evidence can still support high-quality decision-making.
Read the Original
This page is a summary of: Evidence-based practice in times of drug shortage, Journal of Oncology Pharmacy Practice, June 2015, SAGE Publications,
DOI: 10.1177/1078155215589980.
You can read the full text:
Contributors
The following have contributed to this page